These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 25848343)

  • 1. Adjuvant chemotherapy for early female breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline.
    Gandhi S; Fletcher GG; Eisen A; Mates M; Freedman OC; Dent SF; Trudeau ME
    Curr Oncol; 2015 Mar; 22(Suppl 1):S82-94. PubMed ID: 25848343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant endocrine therapy for early breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline.
    Freedman OC; Fletcher GG; Gandhi S; Mates M; Dent SF; Trudeau ME; Eisen A
    Curr Oncol; 2015 Mar; 22(Suppl 1):S95-S113. PubMed ID: 25848344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic targeted therapy for her2-positive early female breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline.
    Mates M; Fletcher GG; Freedman OC; Eisen A; Gandhi S; Trudeau ME; Dent SF
    Curr Oncol; 2015 Mar; 22(Suppl 1):S114-22. PubMed ID: 25848335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal systemic therapy for early breast cancer in women: a clinical practice guideline.
    Eisen A; Fletcher GG; Gandhi S; Mates M; Freedman OC; Dent SF; Trudeau ME;
    Curr Oncol; 2015 Mar; 22(Suppl 1):S67-81. PubMed ID: 25848340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy in early breast cancer.
    Ejlertsen B
    Dan Med J; 2016 May; 63(5):. PubMed ID: 27127018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of Optimal Adjuvant Chemotherapy Regimens for Human Epidermal Growth Factor Receptor 2 (HER2) -Negative and Adjuvant Targeted Therapy for HER2-Positive Breast Cancers: An American Society of Clinical Oncology Guideline Adaptation of the Cancer Care Ontario Clinical Practice Guideline.
    Denduluri N; Somerfield MR; Eisen A; Holloway JN; Hurria A; King TA; Lyman GH; Partridge AH; Telli ML; Trudeau ME; Wolff AC
    J Clin Oncol; 2016 Jul; 34(20):2416-27. PubMed ID: 27091714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
    National Institutes of Health Consensus Development Panel
    J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant therapy for breast cancer.
    NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
    Lancet; 1998 Sep; 352(9132):930-42. PubMed ID: 9752815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adjuvant chemotherapy of early stage breast cancer].
    Boér K
    Orv Hetil; 2010 Feb; 151(9):344-53. PubMed ID: 20159750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of adjuvant chemotherapy for treatment of node-positive breast cancer.
    Trudeau M; Charbonneau F; Gelmon K; Laing K; Latreille J; Mackey J; McLeod D; Pritchard K; Provencher L; Verma S
    Lancet Oncol; 2005 Nov; 6(11):886-98. PubMed ID: 16257797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast irradiation in women with early stage invasive breast cancer following breast conservation surgery. Provincial Breast Disease Site Group.
    Whelan TJ; Lada BM; Laukkanen E; Perera FE; Shelley WE; Levine MN
    Cancer Prev Control; 1997 Aug; 1(3):228-40. PubMed ID: 9765748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant taxanes: more to the story.
    Gajria D; Seidman A; Dang C
    Clin Breast Cancer; 2010 Sep; 10 Suppl 2():S41-9. PubMed ID: 20805064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused Update.
    Denduluri N; Chavez-MacGregor M; Telli ML; Eisen A; Graff SL; Hassett MJ; Holloway JN; Hurria A; King TA; Lyman GH; Partridge AH; Somerfield MR; Trudeau ME; Wolff AC; Giordano SH
    J Clin Oncol; 2018 Aug; 36(23):2433-2443. PubMed ID: 29787356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. American Society of Clinical Oncology endorsement of the cancer care Ontario practice guideline on adjuvant ovarian ablation in the treatment of premenopausal women with early-stage invasive breast cancer.
    Griggs JJ; Somerfield MR; Anderson H; Henry NL; Hudis CA; Khatcheressian JL; Partridge AH; Prestrud AA; Davidson NE
    J Clin Oncol; 2011 Oct; 29(29):3939-42. PubMed ID: 21900112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant therapy for breast cancer.
    Hennessy BT; Pusztai L
    Minerva Ginecol; 2005 Jun; 57(3):305-26. PubMed ID: 16166938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of anthracyclines in the treatment of early breast cancer.
    Greene J; Hennessy B
    J Oncol Pharm Pract; 2015 Jun; 21(3):201-12. PubMed ID: 24769570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic adjuvant therapy for adult patients at high risk for recurrent cutaneous or mucosal melanoma: an Ontario Health (Cancer Care Ontario) clinical practice guideline.
    Petrella TM; Fletcher GG; Knight G; McWhirter E; Rajagopal S; Song X; Baetz TD
    Curr Oncol; 2020 Feb; 27(1):e43-e52. PubMed ID: 32218667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.
    Goble S; Bear HD
    Surg Clin North Am; 2003 Aug; 83(4):943-71. PubMed ID: 12875604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-agent interleukin-2 in the treatment of metastatic melanoma.
    Petrella T; Quirt I; Verma S; Haynes AE; Charette M; Bak K;
    Curr Oncol; 2007 Feb; 14(1):21-6. PubMed ID: 17576460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.